Cytokinetics CYTK
NASDAQ CYTK
$64.29 +0.34 (+0.54%)
As of: Oct 21, 2026 · 10:40 AM EDT

Cytokinetics (CYTK) Work In Process (2026)

Updated

Cytokinetics' Work In Process came in at $994,000 for Q2 2026.

Analysis

Cytokinetics (CYTK) Work In Process (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,131.65 Bn 1,100.24 Bn 19.71 Bn
2 Johnson & Johnson 615.89 Bn 534.41 Bn 17.26 Bn
3 AbbVie 505.03 Bn 478.14 Bn 12.70 Bn
4 Merck 368.78 Bn 323.16 Bn 12.21 Bn
5 Novartis Ag 298.66 Bn 262.65 Bn 11.24 Bn
6 Astrazeneca 262.09 Bn 235.78 Bn 12.86 Bn
7 Amgen 236.57 Bn 191.97 Bn 7.24 Bn
8 Gilead Sciences 191.05 Bn 165.25 Bn 6.22 Bn
9 Pfizer 170.60 Bn 117.25 Bn 10.94 Bn
10 Cytokinetics 8.49 Bn 4.67 Bn 25.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 994,000.00
API Access

Cytokinetics Work In Process API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=work-in-process&ticker=CYTK&period=max&api_key=YOUR_API_KEY